71 related articles for article (PubMed ID: 24461890)
1. Progress in research on screening and genetics in lung cancer.
Hirsch FR; Bunn PA
Lancet Respir Med; 2014 Jan; 2(1):19-21. PubMed ID: 24461890
[No Abstract] [Full Text] [Related]
2. Targeted treatment tested as potential cancer cure.
Hayden EC
Nature; 2011 Nov; 479(7373):281. PubMed ID: 22094668
[No Abstract] [Full Text] [Related]
3. ALK-targeted therapy for lung cancer: ready for prime time.
Husain H; Rudin CM
Oncology (Williston Park); 2011 Jun; 25(7):597-601. PubMed ID: 21888258
[TBL] [Abstract][Full Text] [Related]
4. [Personalized treatment in non-small cell lung cancer].
Campos-Parra AD; Cruz-Rico G; Arrieta O
Rev Invest Clin; 2012; 64(4):377-86. PubMed ID: 23227588
[No Abstract] [Full Text] [Related]
5. Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.
Kim SJ; Kim DW; Kim TM; Lee SH; Heo DS; Bang YJ
J Clin Oncol; 2012 Jun; 30(16):e147-50. PubMed ID: 22508824
[No Abstract] [Full Text] [Related]
6. Targeted therapy for lung cancer.
Petrosyan F; Daw H; Haddad A; Spiro T
Anticancer Drugs; 2012 Nov; 23(10):1016-21. PubMed ID: 22932130
[TBL] [Abstract][Full Text] [Related]
7. PROFILing non-small-cell lung cancer patients for treatment with crizotinib according to anaplastic lymphoma kinase abnormalities: translating science into medicine.
Pilotto S; Peretti U; Novello S; Rossi G; Milella M; Giaj Levra M; Ciuffreda L; Massari F; Brunelli M; Tortora G; Bria E
Expert Opin Pharmacother; 2013 Apr; 14(5):597-608. PubMed ID: 23472711
[TBL] [Abstract][Full Text] [Related]
8. [Current status and perspectives of individualized therapy for non-small cell lung cancer based on molecular targeting].
Shi YK
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):398-400. PubMed ID: 22883466
[No Abstract] [Full Text] [Related]
9. Lung cancer risk models come of age.
Field JK
Cancer Prev Res (Phila); 2008 Sep; 1(4):226-8. PubMed ID: 19138964
[No Abstract] [Full Text] [Related]
10. Crizotinib (xalkori) for non-small cell lung cancer.
Med Lett Drugs Ther; 2012 Feb; 54(1383):11-2. PubMed ID: 22354221
[No Abstract] [Full Text] [Related]
11. Treatment and detection of ALK-rearranged NSCLC.
Peters S; Taron M; Bubendorf L; Blackhall F; Stahel R
Lung Cancer; 2013 Aug; 81(2):145-54. PubMed ID: 23769207
[TBL] [Abstract][Full Text] [Related]
12. ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development.
Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC
Eur J Cancer; 2012 May; 48(7):961-73. PubMed ID: 22397764
[TBL] [Abstract][Full Text] [Related]
13. Successful crizotinib rechallenge after crizotinib-induced interstitial lung disease in patients with advanced non-small-cell lung cancer.
Asai N; Yamaguchi E; Kubo A
Clin Lung Cancer; 2014 May; 15(3):e33-5. PubMed ID: 24702855
[No Abstract] [Full Text] [Related]
14. Are we coming full circle for lung cancer screening a second time?
Bepler G
Am J Respir Crit Care Med; 2009 Sep; 180(5):384-5. PubMed ID: 19700566
[No Abstract] [Full Text] [Related]
15. Crizotinib in the treatment of non--small-cell lung cancer.
Rothschild SI; Gautschi O
Clin Lung Cancer; 2013 Sep; 14(5):473-80. PubMed ID: 23790969
[TBL] [Abstract][Full Text] [Related]
16. Recent therapeutic breakthroughs in respiratory medicine.
Molfino NA
Expert Rev Respir Med; 2013 Aug; 7(4):331-3. PubMed ID: 23964623
[No Abstract] [Full Text] [Related]
17. Is the gene expression pattern of lung cancer detected by screening with spiral computed tomography different from that of symptom-detected lung cancer?
Mulshine JL; Weinstein JN
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5973-4. PubMed ID: 15447979
[No Abstract] [Full Text] [Related]
18. More than just an oncogene translocation and a kinase inhibitor: Kevin's story.
Costa DB
J Clin Oncol; 2012 Jan; 30(1):110-2. PubMed ID: 22067391
[No Abstract] [Full Text] [Related]
19. Screening for early lung cancer with low-dose spiral computed tomography.
Diederich S
Lancet; 2003 Aug; 362(9384):588-9. PubMed ID: 12944053
[No Abstract] [Full Text] [Related]
20. New developments in lung cancer screening.
Mulshine JL
J Clin Oncol; 2005 May; 23(14):3198-202. PubMed ID: 15886306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
